Relationship between radiation response and p53 status in human bladder cancer cells

International Journal of Radiation Biology

Volumn 72, Issue 1, 1997, Pages 11-20

  Ribeiro, J C C ^a   Barnetson, A R ^a   Fisher, R J ^a   Mameghan, H ^a   Russell, P J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DNA REPAIR; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR SUPPRESSOR GENE;

CELL SURVIVAL; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; RADIATION TOLERANCE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0030801050     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530097143491     Document Type: Article

References (43)

1. BIARD, D. S. F., MARTIN, M. L. E., RHUN, Y., DUTHU, A., LEFAIX, J. L., MAY, E. and MAY, P., 1994, Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Research, 54, 3361-3364.
2. BRACHMAN, D. G., BECKETT, M., GRAVES, D., HARAF, D., VOKES, E. and WEICHSELBAUM, R. R., 1993, p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Research, 53, 3667-3669.
3. CAAMANO, J., RUGGERI, B., MOMIKI, S., SICKLER, A., ZHANG, S.Y. and KLEIN-SZANTO, A. J., 1991, Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines. American Journal of Pathology, 139, 839-845.
4. CLARKE, A. R., GLEDHILL, S., HOOPER, M. L., BIRD, C. C. and WYLLIE, A. H., 1994, p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene, 9, 1767-1773.
5. ESRIG, D., SPRUCK, C. H., NICHOLS, P. W., CHAIWUN, B., STEVEN, K., GROSHEN, S., SKINNER, D. G., JONES, P. A. and COTE, R.J., 1993, p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. American Journal of Pathology, 143, 1389-139.
6. FUJIMOTO, K., YAMADA, Y., OKAJIMA, E., KAKIZOE, T., SASAKI, H. and SUGIMURA, T., 1992, Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Research, 52, 1393-1398.
7. GANNON, J. V., GREAVES, R., IGGO, R. and LANE, D. P., 1990, Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. The EMBO Journal, 9, 1595-1602.
8. 1. Proceedings of the National Academy of Sciences, USA, 89, 2759-2763.
9. GOUGH, N.M., 1988, Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Analytical Biochemistry, 173, 93-95.
10. GREENBLATT, M. S., BENNETT, W. P., HOLLSTEIN, M. and HARRIS, C. C., 1994, Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research, 54, 4855-4878.
11. HALL, P. A., MCKEE, P. H., MENAGE, H.D., DOVER, R. and LANE D. P., 1993, High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8, 203-20.
12. ISAACS, W. B., CARTER, B. S. and EWING, C. M., 1991, Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Research, 51, 4716-4720.
13. JACKSON, P., BOS, E. and BRAITHWAITE, A. W., 1993, Wild-type mouse p53 down-regulates transcription from different virus enhancer/promoters. Oncogene, 8, 589-597.
14. JACQUEMIER, J., MOLES, J. P., PENAULT-LLORCA, F., ADELAIDE, J., TORRENTE, M., VIENS, P., BIRNBAUM, D. and THEILLET, C., 1994, p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. British Journal of Cancer, 69, 846-852.
15. KASTAN, M. B., ONYEKWERE, O., SIDRANSKY, D., VOGELSTEIN, B. and CRAIG, R. W., 1991, Participation of p53 protein in the cellular response to DNA damage. Cancer Research, 51, 6304-6311.
16. KAWASHIMA, K., MIHARA, K., USUKI, H., SHIMIZU, N. and NAMBA, M., 1995, Transfected mutant p53 gene increases X-ray-induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells. International Journal of Cancer, 61, 76-79.
17. LEE, J.M. and BERNSTEIN, A., 1993, p53 mutations increase resistance to ionizing radiation. Proceedings of the National Academy of Sciences, USA, 90, 5742-5746.
18. LEVINE, A. J., MOMAND, J. and FINLAY, C. A., 1991, The p53 tumour suppressor gene. Nature, 351, 453-456.
19. LICHER, A. S. and LAWRENCE, T. S., 1995, Medical progress: Recent advances in radiation oncology. The New England Journal of Medicine, 332, 371-379.
20. MADISEN, L, HOAR, D. I., HOLROYD, C. D., CRISP, M. and HODES, M. E., 1987, DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. American Journal of Medical Genetics, 27, 379-390.
21. MCILWRATH, A. J., VASEY, P. A., ROSS, G. M. and BROWN, R., 1994, Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity. Cancer Research, 54, 3718-3722.
22. MICHAEL-MICHALOVITZ, D., YEHIELY, F., GOTTLIEB, E. and OREN, M., 1991, Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding. Journal of Virology, 65, 4160-4168.
23. NIGRO, J. M., BAKER, S. J., PREISINGER, A. C., JESSUP, J. M., HOSTETTER, R., CLEARY, K., BIGNER, S. H., DAVIDSON, N., BAYLIN, S. and DEVILLE, P., 1989, Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
24. O'CONNOR, P. M., JACKMAN, J., JONDLE, D., BHATIA, K., MAGRATH, I. and KOHN, K. W., 1993, Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Research, 53, 4776-4780.
25. ORY, K., LEGROS, Y., AUGUIN, C. and SOUSSI, T., 1994, Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. The EMBO Journal, 13, 3496-3504.
26. REDDEL, R. R., KE, Y., GERWIN, B. I., MCMENAMIN, M. G., LECHNER, J. F., SU, R. T., BRASH, D. E., PARK, J. B., RHIM, J. S. and HARRIS, C. C., 1988, Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Research, 48, 1904-1909.
27. RIBEIRO, J. C. C., HANLEY, J. R. and RUSSELL, P. J., 1996, Studies of X-irradiated bladder cancer cell lines showing differences in p53 status: absence of a p53-dependent cell cycle checkpoint pathway. Oncogene, 13, 1269-1278.
28. RUSSELL, P. J. and GLAVES, D., 1997, Experimental models of bladder cancer. In Principles and Practice of Genitourinary Oncology edited by D. Raghavan, H. I. Scher, S. A. Leibel, and P. H. Lange, (Philadelphia: Lippincott-Raven Publishers), pp. 195-213.
29. RUSSELL, P. J., JELBART, M., WILLS, E., SINGH, S., WASS, J., WOTHERSPOON, J. and RAGHAVAN, D., 1988, Establishment and characterization of a new human bladder cancer cell line showing features of squamous and glandular differentiation. International Journal of Cancer, 41, 74-82.
30. RUSSELL, P. J., PALAVIDIS, Z., ROZINOVA, E., PHILIPS, J., WILLS, E. J., LUKEIS, R., WASS, J. and RAGHAVAN, D., 1993, Characterization of a new human bladder cancer cell line, UCRU-BL-28. The Journal of Urology, 150, 1038-1044.
31. RUSSELL, P. J., WASS, J., LUKEIS, R., GARSON, O. M., JELBART, M., WILLS, E., PHILIPS, J., BROWN, J., CARRINGTON, N. and VINCENT, P.C., 1989, Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13. International Journal of Canter, 44, 276-285.
32. SIDRANSKY, D., VON ESCHENBACH, A., TSAI, Y. C., JONES, P., SUMMERHAYES, I., PAUL, M., GREEN, P., HAMILTON, S. R., FROST, P. and VOGELSTEIN, B., 1991, Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252, 706-709.
33. SLICHENMYER, W. J., NELSON, W. G., SLEBOS, R. J. and KASTAN, M. B., 1993, Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Research, 53, 4164-4168.
34. SMITH, M. L, CHEN, I. T., ZHAN, Q., O'CONNOR, P. M. and FORNACE, A.J. JR., 1995, Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage. Oncogene, 10, 1053-1059.
35. SUN, Y., NAKAMURA, K., WENDEL, E. D. and COLBURN, N.H., 1993a, Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences, USA, 90, 2827-2831.
36. SUN, Y., DONG, Z., NAKAMURA, K. and COLBURN, N. H., 1993b, Dosage-dependent dominance over wild-type p53 of a mutant p53 isolated from nasopharyngeal carcinoma. The FASEB Journal, 7, 944-950.
37. SYMONDS, H., KRALL, L., REMINGTON, L., SAENZ-ROBLES, M., LOWE, S. and JACKS, T., 1994, p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78, 703-711.
38. VOJTESEK, B., BARTEK, J., MIDGLEY, C. A. and LANE, D. P., 1992, An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. Journal of Immunological Methods, 152, 237-244.
39. WEST, C. M. L. and SUTHERLAND, R. M., 1986, A radiobiological comparison of human tumor soft-agar clonogenic assays. International Journal of Cancer, 37, 897-903.
40. WU, J. K., YE, X. and DARRAS, B. T., 1993, Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumors with mixed cell populations. American Journal of Human Genetics, 52, 1273-1275.
41. XIA, F., WANG, Y.-H., TSANG, N.-M., YANDELL, D. W., KELSEY, K. T. and LIBER, H. L., 1995, Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancel Research, 55, 12-15.
42. YEWDELL, J. W., CANNON, J. Y. and LANE, D. P., 1986, Monoclonal antibody analysis of p53 expression in normal and transformed cells. Journal of Virology, 59, 444-452.
43. ZHAN, Q., BAE, I., KASTAN, M. B. and FORNACE, A. J. JR., 1994, The p53-dependent gamma-ray response of GADD45. Cancer Research, 54, 2755-2760.